GENOSYL Drug Patent Profile
✉ Email this page to a colleague
When do Genosyl patents expire, and what generic alternatives are available?
Genosyl is a drug marketed by Vero Biotech Inc and is included in one NDA. There are twenty-four patents protecting this drug.
This drug has sixty patent family members in five countries.
The generic ingredient in GENOSYL is nitric oxide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nitric oxide profile page.
DrugPatentWatch® Generic Entry Outlook for Genosyl
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GENOSYL?
- What are the global sales for GENOSYL?
- What is Average Wholesale Price for GENOSYL?
Summary for GENOSYL
International Patents: | 60 |
US Patents: | 24 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 17 |
Clinical Trials: | 2 |
What excipients (inactive ingredients) are in GENOSYL? | GENOSYL excipients list |
DailyMed Link: | GENOSYL at DailyMed |
Recent Clinical Trials for GENOSYL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Geno LLC | Phase 3 |
Geno LLC | Phase 2 |
Pharmacology for GENOSYL
Drug Class | Vasodilator |
Physiological Effect | Vasodilation |
US Patents and Regulatory Information for GENOSYL
GENOSYL is protected by twenty-four US patents.
Patents protecting GENOSYL
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Nitrogen dioxide storage cassette
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nitrogen dioxide storage device
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Systems and devices for generating nitric oxide
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Nitric oxide therapies
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Kit for the conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Systems and devices for generating nitric oxide
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Systems and devices for generating nitric oxide
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Systems and devices for generating nitric oxide
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR DELIVERING NITRIC OXIDE TO A PATIENT WITH PULMONARY HYPERTENSION OR HYPOXIA
Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Conversion of nitrogen dioxide (NO.sub.2) to nitric oxide (NO)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF DELIVERING NITRIC OXIDE TO A PATIENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GENOSYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vero Biotech Inc | GENOSYL | nitric oxide | GAS;INHALATION | 202860-001 | Dec 20, 2019 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for GENOSYL
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Linde Healthcare AB | INOmax | nitric oxide | EMEA/H/C/000337 INOmax, in conjunction with ventilatory support and other appropriate active substances, is indicated:for the treatment of newborn infants ≥34 weeks gestation with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation;as part of the treatment of peri- and post-operative pulmonary hypertension in adults and newborn infants, infants and toddlers, children and adolescents, ages 0-17 years in conjunction to heart surgery, in order to selectively decrease pulmonary arterial pressure and improve right ventricular function and oxygenation. |
Authorised | no | no | no | 2001-08-01 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for GENOSYL
See the table below for patents covering GENOSYL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2713049 | CONVERSION DE DIOXYDE D'AZOTE (NO |
⤷ Sign Up |
Canada | 2763804 | THERAPIES PAR OXYDE NITRIQUE (NITRIC OXIDE THERAPIES) | ⤷ Sign Up |
Japan | 5950965 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for GENOSYL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0560928 | 2002C/003 | Belgium | ⤷ Sign Up | PRODUCT NAME: NITRIC OXIDE; REGISTRATION NO/DATE: EU/1/01/194/001 20010801 |
0786264 | SPC/GB08/019 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: NITRIC OXIDE (NO); REGISTERED: UK EU/1/01/194/001 20010801 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |